Concerning the total cohort of 194 patients, the median patient age was 59.5 years (ranges from 29 to 89; IQR = 20) and patients were from a range of breast cancer sub-types as determined by ER, PR and HER2 status. Here, ERBB2 is linked to breast cancer.